Close
Nordic 9Nordic 9

Fuho Capital (investor - Venture Capital)

China fuhocapital.com
See something wrong or missing? Let us know
Offices:Beijing
Average round investment:N/A USD
Average number per year:0.0
Distribution: 2026 (1)
Portfolio companies: Switzerland Leman Biotech
Mostly invests in: Switzerland Switzerland (1) Biotech (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Fuho Capital

Name Criteria
Sweden Unionen
77%
  • Range for average deal size: n/a USD
  • Similar verticals: Health services, Pharma, Software Services
  • Similar business models: B2B
  • Active last 12 months: Yes
Sweden Triathlon Group
77%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Active last 12 months: Yes
Sweden Ekeblad Bostad
77%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Active last 12 months: Yes
Italy Golgi NueroSciences
77%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Active last 12 months: Yes
Japan Oji Holdings Corporation
77%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Active last 12 months: Yes
IDO Investments
76%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: Switzerland
Denmark Bagger-Sørensen Equity A/S
76%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Active last 12 months: Yes
Finland DevCo Partners
73%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
Sweden Mertiva
73%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
Xeraya Capital
73%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
Top